³Ô¹Ï±¬ÁÏ Link Adds Four New Data Applications to
Deliver Real-time Intelligence for Medical and Commercial Teams
New Applications: ³Ô¹Ï±¬ÁÏ Link for Key Accounts, ³Ô¹Ï±¬ÁÏ Link for Scientific Awareness,
³Ô¹Ï±¬ÁÏ Link for Medical Insights, and ³Ô¹Ï±¬ÁÏ Link+
PLEASANTON, CA ¡ª April 26, 2022 - ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced new ³Ô¹Ï±¬ÁÏ Link data applications for medical, commercial, and key account management teams to gain real-time intelligence on health systems, scientific awareness and sentiment, and medical insights. In addition, the new Link+ application for agile workflow and relationship management helps medical, commercial, and marketing teams to plan and collaborate on engagement with key scientific and medical experts. These four new Link products join the industry-leading Link for Key People application.
Link data applications are created by a modern data platform that combines intelligent software automation with human curation to ensure accuracy and depth. This allows Link to generate real-time intelligence across a growing number of areas, including key people, accounts, publications, trials, conferences, and digital engagement. The ³Ô¹Ï±¬ÁÏ Link family of data applications now includes:
- ³Ô¹Ï±¬ÁÏ Link for Key People ¨C identify, profile, and keep track of global scientific and medical experts across more than 20 therapeutic areas. Available worldwide.
- ³Ô¹Ï±¬ÁÏ Link for Key Accounts ¨C intelligence on major health systems, including profiles, most important people, and activities. Planned for late 2022.
- ³Ô¹Ï±¬ÁÏ Link for Scientific Awareness ¨C scientific awareness and sentiment data for specific medicines and therapies. Planned for summer 2022.
- ³Ô¹Ï±¬ÁÏ Link for Medical Insights ¨C a workflow application to surface, curate, and share medical insights across the enterprise. Planned for early 2023.
- ³Ô¹Ï±¬ÁÏ Link+ ¨C for agile workflow and relationship management, Link+ helps companies to easily plan, collaborate, and review their engagements with medical and scientific experts across functions and regions. Planned for early 2023.
¡°Organizations need better real-time intelligence to drive medical and commercial excellence,¡± said Kilian Weiss, general manager of ³Ô¹Ï±¬ÁÏ Link. ¡°³Ô¹Ï±¬ÁÏ Link is playing an important role in accelerating insights and advancing engagement so our customers can improve research and care.¡±
³Ô¹Ï±¬ÁÏ Link is part of ³Ô¹Ï±¬ÁÏ Data Cloud, a suite of data products built on a common data architecture. For more information, see the ³Ô¹Ï±¬ÁÏ Summit keynotes on-demand at veeva.com/SummitKeynotes. Life sciences industry professionals can also register for the ³Ô¹Ï±¬ÁÏ Commercial Summit for sales, medical, and marketing in Boston on May 5.
Additional Information
For more on ³Ô¹Ï±¬ÁÏ Link, visit: veeva.com/³Ô¹Ï±¬ÁÏLink
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
Follow @veevasystems on Twitter:
About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world¡¯s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
³Ô¹Ï±¬ÁÏ Forward-looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services, including certain of our new solutions and applications that are still under development or not generally available. These statements are based on our current expectations. Actual results, availability, and any future events relating to these products and services could differ materially from those anticipated or provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the period ended January 31, 2022, which you can find (a summary of risks which may impact our business can be found on pages 13 and 14), and in our subsequent SEC filings, which you can access at .
Contact:
Deivis Mercado
³Ô¹Ï±¬ÁÏ Systems
925-226-8821
deivis.mercado@veeva.com
Jeremy Whittaker
³Ô¹Ï±¬ÁÏ Systems
+49 6950955486
jeremy.whittaker@veeva.com